King Abdullah International Medical Research Center To Host Life Sciences Innovation Forum In Riyadh This October
The King Abdullah International Medical Research Center (KAIMRC), alongside the Ministry of Investment and J.P. Morgan, is preparing to host a forum on life sciences innovation. Scheduled for October 1-2, 2025, it will take place at the King Saud bin Abdulaziz University for Health Sciences conference center in Riyadh. This event aims to boost Saudi Arabia's role as a leader in medical biotechnology and innovation.
The forum will highlight the Kingdom’s efforts to become a global hub in medical biotechnology. It will foster research development and connect international entrepreneurs with local investors, national institutions, and private entities. The event also aims to explore new opportunities for cooperation in drug development, clinical trials, and biomanufacturing.

This initiative aligns with the National Biotechnology Strategy and Saudi Vision 2030 goals. It supports localizing medical biotechnology, transferring knowledge, and creating jobs in a sector crucial for diversifying the national economy. The forum is part of broader national efforts to achieve these strategic objectives.
Participants can expect an engaging program featuring renowned speakers from health, biotechnology, and investment sectors. The event will include specialized workshops and networking sessions designed to facilitate connections between participants and investors. Closed sessions will also be held to support the establishment of local startups.
The forum will welcome 10 distinguished international medium-sized and emerging companies. These companies aim to expand their research efforts and develop innovative therapeutic solutions targeting priority diseases in Saudi Arabia and the broader Middle East region. This collaboration seeks to enhance research capabilities within the Kingdom.
Under the auspices of the Ministry of National Guard through KAIMRC, this two-day event underscores Saudi Arabia's commitment to advancing its position in medical biotechnology. By hosting such forums, the Kingdom aims to attract global attention and investment into its burgeoning life sciences sector.
Overall, this forum represents a significant step towards achieving key national goals while fostering innovation and collaboration in the life sciences field.
With inputs from SPA